131 related articles for article (PubMed ID: 37213092)
21. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
[TBL] [Abstract][Full Text] [Related]
22. Fracture Risk Indices From DXA-Based Finite Element Analysis Predict Incident Fractures Independently From FRAX: The Manitoba BMD Registry.
Leslie WD; Luo Y; Yang S; Goertzen AL; Ahmed S; Delubac I; Lix LM
J Clin Densitom; 2019; 22(3):338-345. PubMed ID: 30852033
[TBL] [Abstract][Full Text] [Related]
23. FRAX® with or without BMD and TBS predicts fragility fractures in community-dwelling rural southern Indian postmenopausal women.
Rajan R; Paul J; Cherian KE; Asha HS; Kapoor N; Paul TV
Arch Osteoporos; 2020 Jun; 15(1):82. PubMed ID: 32483672
[TBL] [Abstract][Full Text] [Related]
24. An optimal intervention threshold of FRAX in postmenopausal Thai women.
Sribenjalak D; Charoensri S; Pongchaiyakul C
Arch Osteoporos; 2022 Jan; 17(1):21. PubMed ID: 35072805
[TBL] [Abstract][Full Text] [Related]
25. Comparison of Clinical Risk Tools for Predicting Osteoporosis in Women Ages 50-64.
Pecina JL; Romanovsky L; Merry SP; Kennel KA; Thacher TD
J Am Board Fam Med; 2016; 29(2):233-9. PubMed ID: 26957380
[TBL] [Abstract][Full Text] [Related]
26. Menopausal hormone therapy reduces the risk of fracture regardless of falls risk or baseline FRAX probability-results from the Women's Health Initiative hormone therapy trials.
Lorentzon M; Johansson H; Harvey NC; Liu E; Vandenput L; Crandall CJ; Cauley JA; LeBoff MS; McCloskey EV; Kanis JA
Osteoporos Int; 2022 Nov; 33(11):2297-2305. PubMed ID: 35833956
[TBL] [Abstract][Full Text] [Related]
27. Bone Mineral Density as a Predictor of Subsequent Wrist Fractures: Findings From the Women's Health Initiative Study.
Crandall CJ; Hovey KM; Andrews CA; Cauley JA; Manson JE; Wactawski-Wende J; Wright NC; Li W; Beavers K; Curtis JR; LeBoff MS
J Clin Endocrinol Metab; 2015 Nov; 100(11):4315-24. PubMed ID: 26367200
[TBL] [Abstract][Full Text] [Related]
28. Screening for Osteoporosis in Older Men: Operating Characteristics of Proposed Strategies for Selecting Men for BMD Testing.
Diem SJ; Peters KW; Gourlay ML; Schousboe JT; Taylor BC; Orwoll ES; Cauley JA; Langsetmo L; Crandall CJ; Ensrud KE;
J Gen Intern Med; 2017 Nov; 32(11):1235-1241. PubMed ID: 28815485
[TBL] [Abstract][Full Text] [Related]
29. Electronic Health Records (EHRs) Can Identify Patients at High Risk of Fracture but Require Substantial Race Adjustments to Currently Available Fracture Risk Calculators.
Jain RK; Weiner M; Polley E; Iwamaye A; Huang E; Vokes T
J Gen Intern Med; 2023 Dec; 38(16):3451-3459. PubMed ID: 37715097
[TBL] [Abstract][Full Text] [Related]
30. Fracture risk assessment tool (FRAX) and for the diagnosis of osteoporosis in Japanese middle-aged and elderly women: Chiba bone survey.
Oka R; Ohira M; Suzuki S; Yoshida T; Koide H; Tanaka T; Tatsuno I
Endocr J; 2018 Feb; 65(2):193-202. PubMed ID: 29151451
[TBL] [Abstract][Full Text] [Related]
31. Setting the new FRAX reference threshold without bone mineral density in Chinese postmenopausal women.
Liu S; Chen R; Ding N; Wang Q; Huang M; Liu H; Xie Z; Ou Y; Sheng Z
J Endocrinol Invest; 2021 Feb; 44(2):347-352. PubMed ID: 32495298
[TBL] [Abstract][Full Text] [Related]
32. A Comparison of US and Canadian Osteoporosis Screening and Treatment Strategies in Postmenopausal Women.
Crandall CJ; Larson J; Manson JE; Cauley JA; LaCroix AZ; Wactawski-Wende J; Datta M; Sattari M; Schousboe JT; Leslie WD; Ensrud KE
J Bone Miner Res; 2019 Apr; 34(4):607-615. PubMed ID: 30536628
[TBL] [Abstract][Full Text] [Related]
33. FRAX provides robust fracture prediction regardless of socioeconomic status.
Brennan SL; Leslie WD; Lix LM; Johansson H; Oden A; McCloskey E; Kanis JA
Osteoporos Int; 2014 Jan; 25(1):61-9. PubMed ID: 24190425
[TBL] [Abstract][Full Text] [Related]
34. Performance of FRAX in clinical practice according to sex and osteoporosis definitions: the Manitoba BMD registry.
Leslie WD; Majumdar SR; Morin SN; Lix LM; Schousboe JT; Ensrud KE; Johansson H; McCloskey EV; Kanis JA
Osteoporos Int; 2018 Mar; 29(3):759-767. PubMed ID: 29404625
[TBL] [Abstract][Full Text] [Related]
35. Performance of Fracture Risk Assessment Tools by Race and Ethnicity: A Systematic Review for the ASBMR Task Force on Clinical Algorithms for Fracture Risk.
Fink HA; Butler ME; Claussen AM; Collins ES; Krohn KM; Taylor BC; Tikabo SS; Vang D; Zerzan NL; Ensrud KE
J Bone Miner Res; 2023 Dec; 38(12):1731-1741. PubMed ID: 37597237
[TBL] [Abstract][Full Text] [Related]
36. Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: sensitivity of the WHO FRAX tool.
Trémollieres FA; Pouillès JM; Drewniak N; Laparra J; Ribot CA; Dargent-Molina P
J Bone Miner Res; 2010 May; 25(5):1002-9. PubMed ID: 20200927
[TBL] [Abstract][Full Text] [Related]
37. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the validity of osteoporosis and fracture risk assessment tools (IOF One Minute Test, SCORE, and FRAX) in postmenopausal Palestinian women.
Kharroubi A; Saba E; Ghannam I; Darwish H
Arch Osteoporos; 2017 Dec; 12(1):6. PubMed ID: 28013446
[TBL] [Abstract][Full Text] [Related]
39. Fracture Rates and Bone Density Among Postmenopausal Veteran and Non-Veteran Women From the Women's Health Initiative.
LaFleur J; Rillamas-Sun E; Colón-Emeric CS; Knippenberg KA; Ensrud KE; Gray SL; Cauley JA; LaCroix AZ
Gerontologist; 2016 Feb; 56 Suppl 1(Suppl 1):S78-90. PubMed ID: 26768394
[TBL] [Abstract][Full Text] [Related]
40. Performance of FRAX and FRAX-Based Treatment Thresholds in Women Aged 40 Years and Older: The Manitoba BMD Registry.
Crandall CJ; Schousboe JT; Morin SN; Lix LM; Leslie W
J Bone Miner Res; 2019 Aug; 34(8):1419-1427. PubMed ID: 30920022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
